Information  X 
Enter a valid email address

GlaxoSmithKline PLC (GSK)

  Print      Mail a friend       Annual reports

Thursday 03 May, 2018

GlaxoSmithKline PLC

Result of AGM

RNS Number : 0988N
GlaxoSmithKline PLC
03 May 2018
 

GlaxoSmithKline plc

 

Result of Annual General Meeting

 

GlaxoSmithKline plc ('GSK') announces that at its Annual General Meeting ('AGM') today, all resolutions were passed by shareholders. The full text of each resolution is contained in the 2018 Notice of AGM which is available on the GSK website at www.gsk.com

 

GSK AGM Poll Results

 

The following table shows the total number of votes cast for each resolution:

 

Resolution

Total votes for*

%

Total votes against

%

Total votes cast

Votes withheld**

1

Receive and adopt the 2017 Annual Report

3,774,060,035

96.85

122,642,168

3.15

3,896,702,203

9,102,585

2

Approve the Annual report on remuneration

2,851,170,418

90.41

302,423,307

9.59

3,153,593,725

752,204,847

3

Election of Dr Hal Barron

3,881,663,314

99.53

18,181,557

0.47

3,899,844,871

5,937,889

4

Election of Dr Laurie Glimcher

3,886,364,801

99.64

13,925,416

0.36

3,900,290,217

5,484,445

5

Re-election of Philip Hampton

3,880,514,761

99.49

19,714,243

0.51

3,900,229,004

5,551,448

6

Re-election of Emma Walmsley

3,885,288,493

99.61

15,236,656

0.39

3,900,525,149

5,261,280

7

Re-election of Vindi Banga

3,874,981,084

99.37

24,610,295

0.63

3,899,591,379

6,184,729

8

Re-election of Dr Vivienne Cox

3,784,417,872

97.05

114,935,231

2.95

3,899,353,103

6,421,540

9

Re-election of Simon Dingemans

3,826,327,989

98.12

73,437,843

1.88

3,899,765,832

6,009,962

10

Re-election of Lynn Elsenhans

3,877,253,828

99.41

23,041,318

0.59

3,900,295,146

5,478,806

11

Re-election of Dr Jesse Goodman

3,886,003,347

99.63

14,266,676

0.37

3,900,270,023

5,506,284

12

Re-election of Judy Lewent

3,794,070,532

97.29

105,710,801

2.71

3,899,781,333

5,994,672

13

Re-election of Urs Rohner

3,871,948,993

99.29

27,625,403

0.71

3,899,574,396

6,201,911

14

Appointment of Deloitte LLP as the auditors

3,892,781,525

99.79

8,074,204

0.21

3,900,855,729

4,930,709

15

Remuneration of auditors

3,889,076,112

99.71

11,291,626

0.29

3,900,367,738

5,413,277

16

Authority for the company to make donations to political organisations and incur political expenditure

3,814,639,515

97.86

83,559,851

2.14

3,898,199,366

7,600,333

17

Authority to allot shares

3,749,621,504

96.23

147,032,649

3.77

3,896,654,153

9,128,625

18

Disapplication of pre-emption rights - general power***

3,792,164,960

97.38

101,981,885

2.62

3,894,146,845

11,614,736

19

Disapplication of pre-emption rights - in connection with an acquisition or specified capital investment***

3,675,122,062

94.36

219,534,966

5.64

3,894,657,028

11,110,220

20

Authority for the company to purchase its own shares***

3,834,088,739

98.40

62,147,383

1.60

3,896,236,122

9,555,694

21

Exemption from statement of senior statutory auditor's name

3,864,323,350

99.16

32,625,496

0.84

3,896,948,846

8,825,695

22

Authority for reduced notice of a general meeting other than an AGM***

3,641,775,376

93.45

255,347,155

6.55

3,897,122,531

8,662,254

23

Approve the adoption of new Articles of Association***

3,883,973,088

99.79

8,108,271

0.21

3,892,081,359

11,790,307

 

Notes:

*

Includes discretionary votes.

**

A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes "For" or "Against" a resolution.

***

Indicates Special Resolutions requiring a 75% majority.

 

The above poll results will shortly be available on the company's website at www.gsk.com.

 

In accordance with Listing Rule 9.6.2, a copy of the resolutions, other than those concerning ordinary business, will be submitted to the UK Listing Authority and will in due course be available for inspection at www.morningstar.co.uk/uk/NSM

 

Professor Sir Roy Anderson did not stand for re-election as a Director and retired from the Board with effect from the conclusion of the AGM.

 

In accordance with section 430(2B) of the Companies Act 2006, GSK confirms that Professor Sir Roy Anderson will receive payment of fees for service whilst a Director but no other remuneration payment or payment for loss of office will be made in connection with his departure.

 

The following table provides further relevant information:

 


 

GSK's

Eighteen

AGM

(2018)

 

GSK's

Seventeenth

AGM

(2017)

Issued share capital (excluding Treasury Shares)

4,959,302,644

4,917,502,476

Total votes cast and votes withheld lodged as a % of GSK's issued share capital (excluding Treasury Shares)

78.76%

74.43%

Total shareholder population

112,326

116,502

Total number of proxies lodged

6,931

7,336

% of shareholders who lodged proxies

6.17%

6.30%

Number of shareholders, corporate representatives and proxies who attended the AGM

415

435

 

 

 

V A Whyte

Company Secretary

3 May 2018

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGFKNDBOBKDNPK

a d v e r t i s e m e n t